Literature DB >> 3882525

Evaluation of pirenzepine on gastric acidity in healthy volunteers using ambulatory 24 hour intragastric pH-monitoring.

A Etienne, C J Fimmel, B A Bron, E Loizeau, A L Blum.   

Abstract

The effect of pirenzepine on 24 hour intragastric acidity was studied in 10 healthy volunteers using ambulatory 24 hour intragastric pH-monitoring in a double blind crossover study. Tests were performed on the seventh day of ingestion of either placebo, 75 mg pirenzepine or 150 mg pirenzepine per day. The drugs were given at two doses at 8.30 am and 8.30 pm. Mean nocturnal hydrogen ion activity during placebo treatment was 68 mmol/l +/- 9 SEM and was reduced by 75 mg (26%, p less than 0.01) and 150 mg of pirenzepine (36%, p less than 0.01), respectively. Mean diurnal hydrogen ion activity was 32 mmol/l +/- 6 SEM and was not significantly reduced (p greater than 0.1) by either dose of pirenzepine (4% and 12% respectively). Thus, the effect of pirenzepine on intragastric acidity is small, even with high doses of the drug, and becomes apparent only during the night.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3882525      PMCID: PMC1432615          DOI: 10.1136/gut.26.3.241

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  9 in total

1.  THE DETERMINATION OF GASTRIC ACIDITY BY THE GLASS ELECTRODE.

Authors:  E W MOORE; R W SCARLATA
Journal:  Gastroenterology       Date:  1965-08       Impact factor: 22.682

2.  Comparison of the action of pirenzepine and L-hyoscyamine on gastric acid secretion and other muscarinic effects.

Authors:  B H Jaup; R W Stockbrügger; G Dotevall
Journal:  Scand J Gastroenterol Suppl       Date:  1980

3.  Reduction of twenty-four-hour gastric acidity with combination drug therapy in patients with duodenal ulcer.

Authors:  W L Peterson; C Barnett; M Feldman; C T Richardson
Journal:  Gastroenterology       Date:  1979-11       Impact factor: 22.682

4.  Treatment of duodenal ulcer with pirenzepine and cimetidine.

Authors:  H Brunner; H Dittrich; P Kratochvil; G Brandstätter; E Hentschel; K Schütze; K H Tragl; H Kern; K Löffelmann; H Zeiler
Journal:  Gut       Date:  1984-02       Impact factor: 23.059

5.  Pirenzepine distinguishes between different subclasses of muscarinic receptors.

Authors:  R Hammer; C P Berrie; N J Birdsall; A S Burgen; E C Hulme
Journal:  Nature       Date:  1980-01-03       Impact factor: 49.962

6.  Rapid healing of duodenal ulcers with omeprazole: double-blind dose-comparative trial.

Authors:  S Gustavsson; H O Adami; L Lööf; A Nyberg; O Nyrén
Journal:  Lancet       Date:  1983-07-16       Impact factor: 79.321

7.  Healing of benign gastric ulcer with low-dose antacid or cimetidine. A double-blind, randomized, placebo-controlled trial.

Authors:  J I Isenberg; W L Peterson; J D Elashoff; M A Sandersfeld; T J Reedy; A F Ippoliti; G M Van Deventer; H Frankl; G F Longstreth; D S Anderson
Journal:  N Engl J Med       Date:  1983-06-02       Impact factor: 91.245

8.  Effect of daily oral omeprazole on 24 hour intragastric acidity.

Authors:  R P Walt; M D Gomes; E C Wood; L H Logan; R E Pounder
Journal:  Br Med J (Clin Res Ed)       Date:  1983-07-02

Review 9.  Pirenzepine in the treatment of peptic ulcer disease. Review and commentary.

Authors:  G Bianchi Porro; M Petrillo
Journal:  Scand J Gastroenterol Suppl       Date:  1982
  9 in total
  11 in total

1.  Pharmacokinetic and pharmacodynamic studies in man simulating acute and chronic treatment with oral pirenzepine.

Authors:  W Londong; V Londong; C Federle; P Tanswell; U Voderholzer
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

2.  Effect of cimetidine and pirenzepine in combination on 24 hour intragastric acidity in subjects with previous duodenal ulceration.

Authors:  J G Williams; M Deakin; J K Ramage
Journal:  Gut       Date:  1986-04       Impact factor: 23.059

3.  Twenty four hour intragastric acidity analysis for the future.

Authors:  R Walt
Journal:  Gut       Date:  1986-01       Impact factor: 23.059

4.  Continuous intravenous infusions of famotidine maintain high intragastric pH in duodenal ulcer.

Authors:  H S Merki; L Witzel; D Kaufman; M Kempf; J Neumann; J Röhmel; R P Walt
Journal:  Gut       Date:  1988-04       Impact factor: 23.059

5.  Double blind comparison of the effects of cimetidine, ranitidine, famotidine, and placebo on intragastric acidity in 30 normal volunteers.

Authors:  H S Merki; L Witzel; R P Walt; J Neumann; E Scheurle; A Mappes; H Krammisch; J Heim; D Kaufmann; J Roehmel
Journal:  Gut       Date:  1988-01       Impact factor: 23.059

6.  Evaluation of antisecretory activity of misoprostol in duodenal ulcer patients using long-term intragastric pH monitoring.

Authors:  V Savarino; P Scalabrini; G S Mela; E di Timoteo; G Percario; M R Magnolia; G Celle
Journal:  Dig Dis Sci       Date:  1988-03       Impact factor: 3.199

Review 7.  Optimizing acid suppression for treatment of acid-related diseases.

Authors:  R H Hunt; C Cederberg; J Dent; F Halter; C Howden; I N Marks; S Rune; R P Walt
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

8.  Single dose treatment with H2 receptor antagonists: is bedtime administration too late?

Authors:  H Merki; L Witzel; K Harre; E Scheurle; J Neumann; J Röhmel
Journal:  Gut       Date:  1987-04       Impact factor: 23.059

9.  Computerized identification of pathologic duodenogastric reflux using 24-hour gastric pH monitoring.

Authors:  K H Fuchs; T R DeMeester; R A Hinder; H J Stein; A P Barlow; N C Gupta
Journal:  Ann Surg       Date:  1991-01       Impact factor: 12.969

10.  Pattern of 24 hour intragastric acidity in active duodenal ulcer disease and in healthy controls.

Authors:  H S Merki; C J Fimmel; R P Walt; K Harre; J Röhmel; L Witzel
Journal:  Gut       Date:  1988-11       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.